Search for: "Sandoz, Inc" Results 281 - 300 of 679
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Jan 2015, 6:24 am by assoulineberlowe
Sandoz, Inc., et al., No. 13-854 (January 20, 2015) that when the district court uses extrinsic evidence during claim construction (information outside of the patent specification itself), the appellate court must use a “clear error” standard of review. [read post]
20 Jan 2015, 9:28 pm by Patent Docs
Sandoz Inc., No. 13-854, slip op. at 1-2 (U.S. [read post]
7 Jan 2015, 10:46 am by Morse, Barnes-Brown Pendleton
By: David Fazzolare On January 5, 2015, the US Food and Drug Administration’s (“FDA’s”) Oncologic Drugs Advisory Committee (the “Committee”) announced its recommendation that the FDA approve Sandoz Inc. [read post]
2 Jan 2015, 8:30 am
Indianapolis, Indiana - In conjunction with co-counsel, an Indiana patent attorney for Eli Lilly and Company of Indianapolis, Indiana sued in the Southern District of Indiana alleging infringement by Sandoz Inc. of Princeton, New Jersey of ALIMTA®, Patent No. 7,772,209, which was issued by the U.S. [read post]
18 Dec 2014, 9:30 pm by Patent Docs
Sandoz Inc. 1:14-cv-02008; filed December 5, 2014 in the Southern District of Indiana Infringement of U.S. [read post]
14 Dec 2014, 9:59 pm by Patent Docs
While consistent with the recent Federal Circuit decision addressing similar issues (see "Sandoz Inc. v. [read post]